CATALOGUE

Foligraf

Pharmaceutical form Package № Dose strength
lyophilisate for solution for injection №1 75 IU

Manufacturer:Bharat Sirams End Vaccines Limited

Recombinant human follicle-stimulating hormone

INDICATIONS

- Anovulation (including polycystic ovarian syndrome in women who turned to be resistant to clomiphene citrate treatment.
- Stimulating multiple follicles development in patients with superovulation by using assisted reproductive treatments such as in vitro fertilization (IVF) , gamete transfer into fallopian tubes (GIFT) and zygote transfer into fallopian tubes (ZIFT).

COMPOSITION

Active ingredient: 1 vial contains 75 IU recombinant human follicle stimulating hormone; Excipients: anhydrous sodium phosphate, mannitol (E 421), saccharose, methionine, polysorbate 20; Solvent: sterile water for injection.

EFFECT

Foligraf ™ presents recombinant human follicle stimulating hormone, obtained by genetic engineering methods from byocytoculture of Chinese hamster ovarian, stimulates follicles growth. It produces gonadotropic (stimulates endometrium proliferation, women, with suppressed endogenic gonadotropin secretion, ovulation) and estrogens (stimulates follicles with ovum growth and maturing, aids in multiple follicles development during monitored ovarian hyperstimulation in assisted reproductive treatment programs) effect. It was shown that Foligraf ™ helps women, with suppressed endogenic gonadotropin secretion, to stimulate follicular development and steroidogenesis.

www.humog-foligraf.com.ua
DO YOU HAVE ANY QUESTIONS?
ASK US!